Sie suchten nach: myelodysplastic syndrome (Englisch - Maltesisch)

malignant melanoma, myelodysplastic syndrome
melanoma malinnia, sindrome majelodisplastiku

acute leukaemia / myelodysplastic syndrome
sindrome ta’ lewkimja akuta/majilodisplastik.

acute leukaemia / myelodysplastic syndrome.
lewkemja akuta/sindromu majelodisplastiku

transformation to leukaemia or myelodysplastic syndrome
it-trasformazzjoni għal-lewkimja jew għas-sindrome majelodisplastiku

myelodysplastic syndrome / acute myeloid leukaemia
sindrome mijelodisplastika / lewkimja majelojda akuta

progression of existing myelodysplastic syndrome (mds)
progressjoni ta’ sindromi mijelodisplastiċi (mds) eżistenti

myelodysplastic syndromes
sindromi majelodisplastiċi

very rare*: acute myeloid leukaemia, myelodysplastic syndrome
rari ħafna*:lewkimja majelojde akuta, sindromu majelodisplastika

malignant diseases including multiple myeloma and myelodysplastic syndrome
mard malinn li jinkludi mjeloma multipla u s-sindrome mjelodisplastiku

myelodysplastic syndromes). in ic
b’ kimoterapija ċitotossika għal tumur malinn (bl- eċċezzjoni ta ’ lewkimja majelojde kronika u sindromi majelodisplastiċi). ot

myelodysplastic syndrome (mds), secondary malignancies, including myeloid leukaemia
sindrome majelodisplastiku (mds - myelodysplastic syndrome), mard sekondarju malinn, inkluż lewkimja majelojde

no patient was diagnosed with myelodysplastic syndrome in either treatment groups.
ebda pazjent ma ġie dijanjonizzat bis-sindromu majelodisplastiku f’kull grupp ta’ trattament.

acute myeloid leukaemia, myelodysplastic syndrome, squamous cell carcinoma of skin**
lewkimja majelodje akuta, sindrome majelodisplastiku, karċinoma tal-ġilda taċ-ċelluli skwamużi

in particular, the risk for osteosarcoma, myelodysplastic syndrome and leukaemias may be increased.
b’mod partikolari, ir-riskju ta’ osteosarkoma, sindrome majelodisplastika u lewkimja jista’ jiżdied.

myelodysplastic syndromes phase ii study
studju ta’ fażi ii dwar sindromi majelodisplastiċi

- tumor pain,, myelodysplastic syndrome / acute myeloid leukaemia (see below)*,
-

at the time of orphan medicine designation, cmml was classified as a type of myelodysplastic syndrome.
fi żmien tad-denominazzjoni bħala orfni, cmml ġie kklassifikat bħala tip ta’ sindromu mjelodisplastiku.

romiplostim may induce the progression of existing haematological malignancies and myelodysplastic syndrome (mds).
romiplostim jista ’ jikkawża l- progressjoni ta ’ tumuri malinni ematoloġiċi eżistenti u tas - sindromè mijelodisplastika (mds).

patients with myeloid leukaemia or myelodysplastic syndromes
pazjenti b’lewkimja majelodje jew sindromi majelodisplastiċi

aml that has developed from a myelodysplastic syndrome and the bone marrow consists of 20 to 30% abnormal cells;
aml li żviluppa minn sindromi mjelodisplastiċi u l-mudullun jikkonsisti f'bejn 20 u 30% ta' ċelloli anormali;